腸内微生物群が人間の健康に与える影響:統合的な見解
Jose C Clemente1, Luke K Ursell, Laura Wegener Parfrey
1Department of Chemistry & Biochemistry, University of Colorado at Boulder, Boulder, CO 80309, USA.
Cell
|March 20, 2012
まとめ
バクテリア,ウイルス,ユカリオットを含むヒトの腸内微生物群は,宿主の健康と病気に影響を与えます. ダイナミックな相互作用を調査する総合的なアプローチは,微生物群に関連した疾患の予測モデルにとって重要です.
科学分野:
- 微生物学 微生物学とは
- 免疫学 免疫学とは
- システム生物学 システム生物学
背景:
- 人間の腸は,宿主の健康に不可欠な多様な微生物群 (微生物群) を宿している.
- 微生物群の構成要素 (細菌,ウイルス,ユカリオット) は,互いに相互作用し,宿主の免疫系と相互作用します.
- これらの相互作用は,疾患の発症に影響を与えます.
研究 の 目的:
- 腸内微生物群と宿主の免疫システムとの複雑な相互作用をレビューする.
- シンプルなコミュニティの構成を超えた総合的な研究アプローチを提唱する.
- 病気の予測と治療におけるダイナミックな相互作用の重要性を強調する.
主な方法:
- ホスト-微生物群と微生物群-微生物群の相互作用に関する既存の文献のレビュー.
- 病気の病原性における微生物コミュニティの役割の分析.
- ダイナミックな相互作用の研究のための概念的枠組みの開発.
主要な成果:
- 微生物群の成分と宿主の免疫系との相互作用は,健康と病気にとって非常に重要です.
- 現在の研究では,ダイナミックな相互作用ではなく,組成に焦点を当てていることが多い.
- これらのダイナミックな相互作用を理解することは,予測モデルの開発に不可欠です.
結論:
- 腸内微生物群を研究するために,全体的でダイナミックなアプローチが不可欠です.
- このアプローチは,微生物群不均衡の疾患の診断と治療のための予測モデルを可能にします.
- 将来の研究は,すべての微生物と宿主成分の時間的動態を統合する必要があります.
関連する概念動画
Probiotics
296
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
296
Introduction to the Human Microbiota
209
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
209
Development of Human Microbiota
61
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
61
The Oral Microbiota
90
The oral microbiome includes a complex ecosystem comprising over 700 microbial species, identified through genomic sequencing and culture-based analyses to date. This community includes a core microbiome, found universally among individuals, and a variable component influenced by environmental factors such as diet, lifestyle, and host genetics. Site-specific conditions, including oxygen gradients, pH levels, and nutrient availability, determine the spatial distribution of these microorganisms...
90
Functions of the Gut Microbiota
233
The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
233
Gut-Brain Axis
222
The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such...
222


